Kezar Life Sciences Inc KZR:NASDAQ

Last Price$10.13NASDAQ Closing Price as of 4:00PM ET 8/19/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change+0.18(1.81%)
Bid (Size)$10.11 (49)
Ask (Size)$10.63 (2)
Day Low / High$9.79 - 10.15
Volume459.5 K
 

View Biotechnology IndustryPeer Comparison as of 08/19/2022

 

Kezar Life Sciences Inc ( NASDAQ )

Price: $10.13
Change: +0.18 (1.81%)
Volume: 459.5 K
4:00PM ET 8/19/2022
 
 

NanoString Technologies Inc ( NASDAQ )

Price: $13.25
Change: -1.18 (8.18%)
Volume: 636.6 K
3:59PM ET 8/19/2022
 
 

AnaptysBio Inc ( NASDAQ )

Price: $25.23
Change: +0.38 (1.53%)
Volume: 258.5 K
4:00PM ET 8/19/2022
 
 

Seres Therapeutics Inc ( NASDAQ )

Price: $5.47
Change: -0.19 (3.36%)
Volume: 809.8 K
4:00PM ET 8/19/2022
 
 

Mersana Therapeutics Inc ( NASDAQ )

Price: $7.48
Change: +0.05 (0.67%)
Volume: 758.9 K
4:00PM ET 8/19/2022
 

Read more news Recent News

-- Earnings Flash (KZR) KEZAR LIFE SCIENCES Reports Q2 Loss $-0.25
4:04PM ET 8/11/2022 MT Newswires

...

Kezar Life Sciences Appoints Nick Mordwink as Chief Business Officer
4:37PM ET 7/11/2022 MT Newswires

Kezar Life Sciences (KZR) said late Monday that it has appointed Nick Mordwinkin as chief business officer of the company. Mordwinkin joins the...

Sector Update: Health Care Stocks Decline Tuesday but Largely Outperform Most Other Sectors
4:00PM ET 6/28/2022 MT Newswires

Health care stocks still were mostly lower this afternoon, with the NYSE Health Care Index and the SPDR Health Care Select Sector ETF (XLV) both falling...

Sector Update: Health Care Stocks Lower in Afternoon Trade
2:03PM ET 6/28/2022 MT Newswires

Health care stocks were mostly lower this afternoon, with the NYSE Health Care Index falling 1.6% and the SPDR Health Care Select Sector ETF (XLV) slipping...

View all Commentary and Analysis

Monster Moves Among Russell 3,000 Stocks
2:40AM ET 8/09/2022 Seeking Alpha

Kezar Life Sciences: Regulatory Tailwinds Reverse Downside Case
1:45PM ET 7/27/2022 Seeking Alpha

Insider Weekends: Return Of The Meme Stocks - GameStop And AMC Entertainment
8:53AM ET 3/28/2022 Seeking Alpha

Kezar Life Sciences (KZR) Corporate Overview
4:03PM ET 9/10/2021 Seeking Alpha

Company Profile

Business DescriptionKezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer in South San Francisco and California. Its product pipeline include KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA. View company web site for more details
Address4000 Shoreline Court
South San Francisco, California 94080
Phone+1.650.822.5600
Number of Employees24
Recent SEC Filing08/11/202210-Q
Chief Executive Officer & DirectorJohn Fowler
President, Director & Chief Scientific OfficerChristopher J. Kirk
Director-Finance & Business OperationsMichael Wolfe
Chief Financial Officer & SecretaryMarc L. Belsky

Company Highlights

Price Open$9.97
Previous Close$9.95
52 Week Range$4.31 - 18.55
Market Capitalization$612.0 M
Shares Outstanding60.4 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement11/08/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.05
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit MarginN/A
Return on Equity-28.79%

Analyst Ratings as of 06/27/2022

Buy
6
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset